The SITC Forward Fund is pleased to announce the recipients of 2021 SITC Fellowships to support the next generation of cancer immunotherapy and tumor immunology experts through dedicated funding of impactful research.
The 2021 SITC Fellowships recipients are:
SITC-Bristol Myers Squibb Postdoctoral Cancer Immunotherapy Translational FellowshipRecipient: Karlo Perica, MD, PhDInstitution: Memorial Sloan Kettering Cancer Center Project Title: “Allogeneic CAR T Cell Therapy: Overcoming Host-Versus-Graft Immunity”Award Amount: $200,000 (two-year)
SITC-Amgen Cancer Immunotherapy in Hematologic Malignancies FellowshipRecipient: Benjamin Goldenson, MD, PhDInstitution: University of California, San Diego Project Title: “Chimeric Antigen Receptor Natural Killer Cells for the Treatment of Acute Myeloid Leukemia”Award Amount: $100,000 (one-year)
SITC-AstraZeneca Immunotherapy in Lung Cancer Clinical FellowshipRecipient: Biagio Ricciuti, MDInstitution: Dana-Farber Cancer InstituteProject Title: “Dissecting the genomic correlates of response and acquired resistance to PD-(L)1 inhibition in non-small cell lung cancer”Award Amount: $100,000 (one-year)
SITC-Nektar Therapeutics Equity and Inclusion in Cancer Immunotherapy FellowshipRecipient: Elen Torres, PhDInstitution: Koch Institute for Integrative Cancer Research at MITProject Title: “The role of tumor cell-intrinsic Sox2 in the anti-tumor immune response in non-small cell lung cancer (NSCLC)”Award Amount: $50,000 (one-year)
2021 NCI Immunotherapy FellowshipRecipient: Vincent I. Poon, MDInstitution: BC Cancer VancouverAward: Co-Sponsored by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) and SITC, made possible in part by an educational grant from EMD Serono. This 1-year program allows the fellow to have exposure to multiple clinical immunotherapeutic approaches and also to key opinion leaders in the field of clinical immunotherapy. Click here for more information on this fellowship.
The 2021 SITC Fellowships were made possible through the generosity of Amgen, AstraZeneca Pharmaceuticals LP, Bristol Myers Squibb, EMD Serono and Nektar Therapeutics
Interested in supporting a fellowship? Contact SITC Development at firstname.lastname@example.org or +1 414-271-2456.
Also, visit our Frequently Asked Questions page for more details about the SITC Fellowship Awards.
Looking to view past recipients of SITC Fellowship Awards? Click the links below:
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com